Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 9—September 2016

Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge

Nurcan Soysal, Patricia Mariani-Kurkdjian, Yasmine Smail, Sandrine Liguori, Malika Gouali, Estelle Loukiadis, Patrick Fach, Mathias Bruyand, Jorge Blanco, Philippe Bidet, and Stéphane BonacorsiComments to Author 
Author affiliations: Centre Hospitalo-Universitaire Robert-Debré (AP-HP), Paris, France (N. Soysal, P. Mariani-Kurkdjian, Y. Smail, S. Liguori, P. Bidet, S. Bonacorsi); Institut National de la Santé et de la Recherche Médicale, Paris (N. Soysal, P. Mariani-Kurkdjian, P. Bidet, S. Bonacorsi); Université Paris Diderot, Paris (N. Soysal, P. Mariani-Kurkdjian, P. Bidet, S. Bonacorsi); Institut Pasteur, Paris (M. Gouali); Laboratoire National de Réference pour les Escherichia coli, Marcy l’Etoile, France (E. Loukiadis); ANSES, Maison-Alfort, France (P. Fach); Institut de Veille Sanitaire, Saint Maurice, France (M. Bruyand); Universidade de Santiago de Compostela, Lugo, Spain (J. Blanco)

Main Article


Antibiotic susceptibility of enterohemorrhagic Escherichia coli O80:H2 and O157:H7 isolates used in an antibiotics assay, France, January 2005–October 2014

Isolate (source)
MIC, µg/mL
35344 (stool) O80:H2 1 0.5 0.25
35431 (blood) O80:H2 16 0.5 0.06
33115 (pancreas) O80:H2 16 0.25 0.06
36047 (stool) O80:H2 16 0.06 0.06
EDL933 (ground beef) O157:H7 32 0.12 0.12

Main Article

Page created: August 16, 2016
Page updated: August 16, 2016
Page reviewed: August 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.